These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7509133)

  • 1. Incidence of CD4+ IL-2R alpha+ and CD4+ CD45RA+ T-cells in progressive multiple sclerosis and the influence of short-term (3 months) FK 506 therapy.
    Thomson AW; Woo J; Lemster B; Irish W; Huang LL; Carroll PB; Rilo HR; Abu-Elmagd K; Eidelman B
    Ann N Y Acad Sci; 1993 Nov; 696():245-9. PubMed ID: 7509133
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of FK 506 (tacrolimus) on circulating CD4+ T cells expressing CD25 and CD45RA antigens in 19 patients with chronic progressive multiple sclerosis participating in an open label drug safety trial.
    Lemster B; Huang LL; Irish W; Woo J; Carroll PB; Abu-Elmagd K; Rilo HR; Johnson N; Russell-Hall R; Fung JJ
    Autoimmunity; 1994; 19(2):89-98. PubMed ID: 7539635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel subpopulation of CD45RA+ CD4+ T cells expressing IL-2 receptor alpha-chain (CD25) and having a functionally transitional nature into memory cells.
    Kanegane H; Miyawaki T; Kato K; Yokoi T; Uehara T; Yachie A; Taniguchi N
    Int Immunol; 1991 Dec; 3(12):1349-56. PubMed ID: 1685671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the progression of multiple sclerosis by linomide is associated with upregulation of CD4+/CD45RA+ cells and downregulation of CD4+/CD45RO+ cells.
    Lehmann D; Karussis D; Mizrachi-Koll R; Linde AS; Abramsky O
    Clin Immunol Immunopathol; 1997 Nov; 85(2):202-9. PubMed ID: 9344704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of human CD4+CD45RA+ T cells by chrysotile asbestos in vitro.
    Kinugawa K; Ueki A; Yamaguchi M; Watanabe Y; Kawakami Y; Hyodoh F; Tsushima H
    Cancer Lett; 1992 Sep; 66(2):99-106. PubMed ID: 1382835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Memory and naive CD4+ lymphocytes in multiple sclerosis.
    Porrini AM; Gambi D; Malatesta G
    J Neurol; 1992 Oct; 239(8):437-40. PubMed ID: 1360022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-course of interleukin-2 receptor expression in interferon beta-treated multiple sclerosis patients.
    Ferrarini AM; Sivieri S; Bulian P; Buttarello M; Biasi G; Tavolato B; Gallo P
    J Neuroimmunol; 1998 Apr; 84(2):213-7. PubMed ID: 9628465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating CD4+CD25+ T regulatory cells are not altered in multiple sclerosis and unaffected by disease-modulating drugs.
    Putheti P; Pettersson A; Soderstrom M; Link H; Huang YM
    J Clin Immunol; 2004 Mar; 24(2):155-61. PubMed ID: 15024182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis.
    Stüve O; Marra CM; Bar-Or A; Niino M; Cravens PD; Cepok S; Frohman EM; Phillips JT; Arendt G; Jerome KR; Cook L; Grand'Maison F; Hemmer B; Monson NL; Racke MK
    Arch Neurol; 2006 Oct; 63(10):1383-7. PubMed ID: 17030653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of interleukin-2 receptor by activated peripheral blood lymphocytes upregulated by the plasma level of interleukin-2 in patients with recurrent aphthous ulcers.
    Sun A; Chu CT; Liu BY; Wang JT; Leu JS; Chiang CP
    Proc Natl Sci Counc Repub China B; 2000 Jul; 24(3):116-22. PubMed ID: 10943944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose methylprednisolone treatment-induced changes in immunological parameters in progressive MS patients.
    Dufour A; Salmaggi A; La Mantia L; Eoli M; Nespolo A; Milanese C
    Int J Neurosci; 1994 Mar; 75(1-2):119-28. PubMed ID: 7914185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of interleukin-7 and -15 on activation of purified umbilical cord blood and adult peripheral blood CD4+ T cells.
    Lin SJ; Cheng PJ
    Biol Neonate; 2004; 85(1):3-10. PubMed ID: 14631159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune memory in CD4+ CD45RA+ T cells.
    Richards D; Chapman MD; Sasama J; Lee TH; Kemeny DM
    Immunology; 1997 Jul; 91(3):331-9. PubMed ID: 9301520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased CD69 and human leukocyte antigen-DR expression on T lymphocytes in insulin-dependent diabetes mellitus of long standing.
    Gessl A; Waldhäusl W
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2204-9. PubMed ID: 9626161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8+CD45RA+ in HIV-infected patients are predominantly CD11abright.
    Scala E; Bellioni B; Guerra EC; Aiuti F; Paganelli R
    AIDS; 1995 Jun; 9(6):653-4. PubMed ID: 7662209
    [No Abstract]   [Full Text] [Related]  

  • 16. Age-related modifications of the human alphabeta T cell repertoire due to different clonal expansions in the CD4+ and CD8+ subsets.
    Wack A; Cossarizza A; Heltai S; Barbieri D; D'Addato S; Fransceschi C; Dellabona P; Casorati G
    Int Immunol; 1998 Sep; 10(9):1281-8. PubMed ID: 9786427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple sclerosis: pathophysiology revisited.
    Sorensen PS
    Lancet Neurol; 2005 Jan; 4(1):9-10. PubMed ID: 15620850
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential effect of cholera toxin on CD45RA+ and CD45RO+ T cells: specific inhibition of cytokine production but not proliferation of human naive T cells.
    Eriksson K; Nordström I; Czerkinsky C; Holmgren J
    Clin Exp Immunol; 2000 Aug; 121(2):283-8. PubMed ID: 10931143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloantigen-specific T suppressor-inducer and T suppressor-effector cells can be activated despite blocking the IL-2 receptor.
    Tan P; Anasetti C; Martin PJ; Hansen JA
    J Immunol; 1990 Jul; 145(2):485-8. PubMed ID: 1973183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.